Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS.
BACKGROUND:Decreased but measurable serum IgA levels (≤70 mg/dL) have been associated with risk for infections in some populations, but are unstudied in COPD. This study tested the hypothesis that subnormal serum IgA levels would be associated with exacerbation risk in COPD. METHODS:Data were analyz...
Main Authors: | Nirupama Putcha, Gabriel G Paul, Antoine Azar, Robert A Wise, Wanda K O'Neal, Mark T Dransfield, Prescott G Woodruff, Jeffrey L Curtis, Alejandro P Comellas, M Bradley Drummond, Allison A Lambert, Laura M Paulin, Ashraf Fawzy, Richard E Kanner, Robert Paine, MeiLan K Han, Fernando J Martinez, Russell P Bowler, R Graham Barr, Nadia N Hansel, SPIROMICS investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5896903?pdf=render |
Similar Items
-
Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts
by: Ashraf Fawzy, et al.
Published: (2018-01-01) -
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort
by: Stott-Miller M, et al.
Published: (2020-10-01) -
Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the Spiromics Cohort
by: Cooper CB, et al.
Published: (2020-08-01) -
The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS
by: J. Michael Wells, et al.
Published: (2019-11-01) -
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort
by: Kristopher Opron, et al.
Published: (2021-02-01)